news
Scientists at UTHealth Houston have developed an agonistic antibody that…
21 September 2022 | By Ria Kakkad (Drug Target Review)
Scientists at UTHealth Houston have developed an agonistic antibody that reduced the amyloid pathology in mice with Alzheimer’s disease.